Chiral nanosystem and chiral supraparticles for drug delivery: an expert opinion

Mahfoozur Rahman, Janhvi Singh, Alhussain Aodah, Majed Alrobaian, Nabil K. Alruwaili, Waleed H. Almalki, Salem Salman Almujri, Safia Obaidur Rab, Osama A. Madkhali, Ankit Sahoo, Jonathan A. Lal

Research output: Contribution to journalReview articlepeer-review

Abstract

Introduction: Chiral nanocarriers enhance therapeutic efficacy by improving in vivo stability and cellular uptake. Chemical functionalization reduces cytotoxicity, resulting in favorable biocompatibility. Nanoparticles self-assemble into supraparticles, enhancing drug delivery through improved retention and drug loading. Area covered: This review covers chiral nanostructures and chiral supraparticles, and their applications in drug delivery and various healthcare applications. Expert opinion: The chirality of biomaterials is crucial for advancing nanomedicine. Chiral nanosystem enhance drug delivery by interacting selectively with biological molecules, improving their specificity and efficacy. This reduces off-target effects and improves therapeutic outcomes. Research has focused on cellular uptake and elimination to ensure safety, and chiral nanomaterials also show promise in optical sensing and gene editing. Their biocompatibility and ability to self-assemble into supraparticles may make them ideal for drug delivery systems.

Original languageEnglish
Pages (from-to)143-162
Number of pages20
JournalExpert Opinion on Drug Delivery
Volume22
Issue number2
DOIs
StatePublished - 2025

Keywords

  • Alzheimer’s
  • Chiral nanoparticles
  • D-L-Peptides
  • antimicrobial action
  • cancer
  • chiral supraparticles

Fingerprint

Dive into the research topics of 'Chiral nanosystem and chiral supraparticles for drug delivery: an expert opinion'. Together they form a unique fingerprint.

Cite this